ABBOTT INDIA
|
The Current P/S Ratio of ABBOTT INDIA is 8.02.
| Share Price | ₹26,220.8 | Jun 19,2026 |
| Market Cap | ₹55,588.1 Cr | |
| Sales-TTM | ₹6,929.1 Cr | TTM-Standalone Results |
| Price/Sales | 8.02x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ABBOTT INDIA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹55,588.1 Cr] as on Jun 19,2026
(/) Sales [ ₹6,929.1 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 8.02x ]
Thus, for ABBOTT INDIA , the investors are currently willing to pay '8.02 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ABBOTT INDIA !
The chart below summarizes the trend in P/S Ratio of ABBOTT INDIA over the last five years.
Historical PS (Price/Sales) ratio chart of ABBOTT INDIA
PS Ratio Performance Analysis for ABBOTT INDIA
- ABBOTT INDIA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 8.76x.
- ABBOTT INDIA 's operated at median p/e ratio of 8.77x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ABBOTT INDIA 's p/e ratio peaked in Mar2025 at 10.19x.
- ABBOTT INDIA 's p/e ratio hit its five-year low in Mar2021 of 7.39x.
How does ABBOTT INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ABBOTT INDIA | 6,929.1 | 8.02 | 55,588.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.54 | 440,794.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.95 | 178,956.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 10.72 | 149,820.0 |
| CIPLA LTD | 28,162.6 | 3.88 | 109,370.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.15 | 106,133.0 |
| MANKIND PHARMA LTD | 14,277.6 | 6.99 | 99,835.6 |
| LUPIN LTD | 27,958.0 | 3.85 | 107,537.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 3.97 | 107,758.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.56 | 86,183.0 |
| LAURUS LABS LTD | 6,812.9 | 11.20 | 76,323.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ABBOTT INDIA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.56x |
| Max industry PS | 16.95x |
| Median industry PS | 6.99x |
| Average industry PS | 7.17x |
You may also like the below Video Courses